FR22C1047I1 - Derives de benzimidazole-proline - Google Patents
Derives de benzimidazole-prolineInfo
- Publication number
- FR22C1047I1 FR22C1047I1 FR22C1047C FR22C1047C FR22C1047I1 FR 22C1047 I1 FR22C1047 I1 FR 22C1047I1 FR 22C1047 C FR22C1047 C FR 22C1047C FR 22C1047 C FR22C1047 C FR 22C1047C FR 22C1047 I1 FR22C1047 I1 FR 22C1047I1
- Authority
- FR
- France
- Prior art keywords
- benzimidazole
- proline derivatives
- proline
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Nutrition Science (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12170748 | 2012-06-04 | ||
EP13158520 | 2013-03-11 | ||
PCT/IB2013/054567 WO2013182972A1 (fr) | 2012-06-04 | 2013-06-03 | Dérivés de benzimidazole-proline |
EP13744805.6A EP2855453B1 (fr) | 2012-06-04 | 2013-06-03 | Dérivés de benzimidazole-proline |
Publications (2)
Publication Number | Publication Date |
---|---|
FR22C1047I1 true FR22C1047I1 (fr) | 2022-10-14 |
FR22C1047I2 FR22C1047I2 (fr) | 2023-08-18 |
Family
ID=48914370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR22C1047C Active FR22C1047I2 (fr) | 2012-06-04 | 2022-09-13 | Derives de benzimidazole-proline |
Country Status (33)
Country | Link |
---|---|
US (3) | US9732075B2 (fr) |
EP (1) | EP2855453B1 (fr) |
JP (1) | JP5814491B2 (fr) |
KR (3) | KR101689093B1 (fr) |
CN (1) | CN104334544B (fr) |
AR (1) | AR091257A1 (fr) |
AU (1) | AU2013273222B2 (fr) |
BR (1) | BR112014030173B1 (fr) |
CA (1) | CA2873341C (fr) |
CL (1) | CL2014003294A1 (fr) |
CY (1) | CY1118735T1 (fr) |
DK (1) | DK2855453T3 (fr) |
EA (2) | EA028046B1 (fr) |
ES (1) | ES2617863T3 (fr) |
FR (1) | FR22C1047I2 (fr) |
HK (1) | HK1208449A1 (fr) |
HR (1) | HRP20170351T1 (fr) |
HU (2) | HUE031753T2 (fr) |
IL (1) | IL236024A (fr) |
LT (2) | LT2855453T (fr) |
MX (1) | MX354102B (fr) |
MY (1) | MY169986A (fr) |
NL (1) | NL301197I2 (fr) |
NO (1) | NO2022044I1 (fr) |
NZ (1) | NZ703448A (fr) |
PH (1) | PH12014502540A1 (fr) |
PL (1) | PL2855453T3 (fr) |
PT (1) | PT2855453T (fr) |
SG (2) | SG11201408004SA (fr) |
SI (1) | SI2855453T1 (fr) |
TW (2) | TWI570120B (fr) |
WO (1) | WO2013182972A1 (fr) |
ZA (1) | ZA201409422B (fr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2807000C (fr) | 2010-08-24 | 2018-12-04 | Actelion Pharmaceuticals Ltd | Derives de proline sulfonamide comme antagonistes des recepteurs de l'orexine |
EP2855453B1 (fr) | 2012-06-04 | 2016-12-07 | Actelion Pharmaceuticals Ltd. | Dérivés de benzimidazole-proline |
CN104703980B (zh) | 2012-10-10 | 2017-09-22 | 埃科特莱茵药品有限公司 | 属于[邻双(杂)芳基]‑[2‑(间双(杂)芳基)吡咯烷‑1‑基]甲酮衍生物的食欲素受体拮抗剂 |
KR20150130413A (ko) | 2013-03-12 | 2015-11-23 | 액테리온 파마슈티칼 리미티드 | 오렉신 수용체 길항제로서의 아제티딘 아미드 유도체 |
SG11201600504TA (en) | 2013-07-22 | 2016-02-26 | Actelion Pharmaceuticals Ltd | 1-(piperazin-1-yl)-2-([1,2,4]triazol-1-yl)-ethanone derivatives |
PT3077389T (pt) | 2013-12-03 | 2017-12-15 | Idorsia Pharmaceuticals Ltd | Forma cristalina de (s)-(2-(6-cloro-7-metil-1hbenzo[d]imidazol-2-il)-2-metilpirrolidin-1-il)(5-metoxi-2-(2h-1,2,3-triazol-2-il)fenil)metanona e a sua utilização como como antagonistas do receptor de orexina |
UA119151C2 (uk) * | 2013-12-03 | 2019-05-10 | Ідорсія Фармасьютікалз Лтд | КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА |
LT3077391T (lt) * | 2013-12-04 | 2018-10-25 | Idorsia Pharmaceuticals Ltd | Benzimidazolo prolino darinių panaudojimas |
KR20160124188A (ko) * | 2014-02-20 | 2016-10-26 | 다케다 파머수티컬 컴패니 리미티드 | 오렉신 수용체 길항제로서의 치환된 시클로펜탄, 테트라히드로푸란 및 피롤리딘 |
TW201613864A (en) * | 2014-02-20 | 2016-04-16 | Takeda Pharmaceutical | Novel compounds |
AR103399A1 (es) | 2015-01-15 | 2017-05-10 | Actelion Pharmaceuticals Ltd | Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3 |
ES2709985T3 (es) * | 2015-01-15 | 2019-04-22 | Idorsia Pharmaceuticals Ltd | Derivados de hidroxialquil-piperazina como moduladores del receptor CXCR3 |
AU2016295693B2 (en) | 2015-07-17 | 2020-05-21 | Sunshine Lake Pharma Co., Ltd. | Substituted quinazoline compounds and preparation and uses thereof |
TWI734702B (zh) | 2015-10-01 | 2021-08-01 | 美商百歐克斯製藥公司 | 人類血漿激肽釋放酶抑制劑 |
AU2016360245B2 (en) | 2015-11-23 | 2020-07-09 | Sunshine Lake Pharma Co., Ltd. | Octahydropyrrolo [3, 4-c] pyrrole derivatives and uses thereof |
CN110612291B (zh) | 2017-05-03 | 2024-02-13 | 爱杜西亚药品有限公司 | 2-([1,2,3]三唑-2-基)-苯甲酸衍生物的制备 |
WO2019002344A1 (fr) | 2017-06-29 | 2019-01-03 | Lonza Guangzhou Nansha Ltd. | Procédé de préparation d'alpha-méthyl-l-proline |
WO2020007964A1 (fr) | 2018-07-05 | 2020-01-09 | Idorsia Pharmaceuticals Ltd | Dérivés de 2-(2-azabicyclo [3.1.0] hexan-1-yl)-1h-benzimidazole |
WO2020007977A1 (fr) | 2018-07-06 | 2020-01-09 | Idorsia Pharmaceuticals Ltd | Dérivés de 7-trifluorométhyl-[1,4]diazépane |
CN108997308A (zh) * | 2018-07-09 | 2018-12-14 | 西藏大学 | 一种苯并咪唑类衍生物及其制备方法和应用 |
WO2020099511A1 (fr) | 2018-11-14 | 2020-05-22 | Idorsia Pharmaceuticals Ltd | Dérivés de benzimidazole-2-méthyl-morpholine |
EP4138822A1 (fr) | 2020-04-19 | 2023-03-01 | Idorsia Pharmaceuticals Ltd | Utilisation médicale de daridorexant |
WO2022166768A1 (fr) * | 2021-02-02 | 2022-08-11 | 南京明德新药研发有限公司 | Composé tétrahydropyrrolocyclique et son application |
WO2023160004A1 (fr) * | 2022-02-25 | 2023-08-31 | 南京知和医药科技有限公司 | Composé à cycle fusionné ayant une activité analgésique, son procédé de préparation et son utilisation |
TW202400149A (zh) | 2022-05-13 | 2024-01-01 | 瑞士商愛杜西亞製藥有限公司 | 經噻唑并芳基-甲基取代之環狀肼-n-甲醯胺衍生物 |
CN117736193A (zh) * | 2023-12-19 | 2024-03-22 | 南京知和医药科技有限公司 | 一种氘代稠环化合物及其制备方法与用途 |
Family Cites Families (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3282927A (en) | 1964-05-21 | 1966-11-01 | Bristol Myers Co | 5-phenyl-4-thiazolylpenicillins |
AUPQ253199A0 (en) | 1999-08-30 | 1999-09-23 | Fujisawa Pharmaceutical Co., Ltd. | Non-prostanoid prostaglandin I2-agonist |
DE60110066T2 (de) | 2000-06-16 | 2006-02-02 | Smithkline Beecham P.L.C., Brentford | Piperidine zur verwendung als orexinrezeptorantagonisten |
KR20030060904A (ko) | 2000-10-06 | 2003-07-16 | 뉴로젠 코포레이션 | Crf 수용체 조절자로서 벤즈이미다졸 및 인돌 유도체 |
US6943160B2 (en) | 2000-11-28 | 2005-09-13 | Smithkline Beecham Plc | Morpholine derivatives as antagonists of orexin receptors |
US7432270B2 (en) | 2001-05-05 | 2008-10-07 | Smithkline Beecham P.L.C. | N-aroyl cyclic amines |
JP2004534026A (ja) | 2001-05-05 | 2004-11-11 | スミスクライン ビーチャム パブリック リミテッド カンパニー | オレキシン受容体アンタゴニストとしてのn−アロイルサイクリックアミン誘導体 |
GB0115862D0 (en) | 2001-06-28 | 2001-08-22 | Smithkline Beecham Plc | Compounds |
MXPA03011706A (es) * | 2001-06-28 | 2004-03-19 | Smithkline Beecham Plc | Derivados de n-aroil-amina ciclica como antagonistas del receptor de orexina. |
GB0124463D0 (en) | 2001-10-11 | 2001-12-05 | Smithkline Beecham Plc | Compounds |
GB0127145D0 (en) | 2001-11-10 | 2002-01-02 | Smithkline Beecham | Compounds |
GB0130393D0 (en) | 2001-12-19 | 2002-02-06 | Smithkline Beecham Plc | Compounds |
GB0130335D0 (en) | 2001-12-19 | 2002-02-06 | Smithkline Beecham Plc | Compounds |
DE10240818A1 (de) | 2002-08-30 | 2004-05-13 | Grünenthal GmbH | Substituierte 2-Pyrrolidin-2-yl-[1,3,4]-oxadiazol-Derivate |
EP1539747B1 (fr) | 2002-09-18 | 2006-11-02 | Glaxo Group Limited | Amines cycliques n-aroyle utilisees comme antagonistes du recepteur d'orexine |
GB0225944D0 (en) | 2002-11-06 | 2002-12-11 | Glaxo Group Ltd | Novel compounds |
GB0225938D0 (en) | 2002-11-06 | 2002-12-11 | Glaxo Group Ltd | Novel compounds |
GB0225884D0 (en) | 2002-11-06 | 2002-12-11 | Glaxo Group Ltd | Novel compounds |
PE20050226A1 (es) | 2003-06-04 | 2005-05-18 | Aventis Pharma Sa | Productos aril-heteroaromaticos y composiciones que los contienen |
GB0325956D0 (en) | 2003-11-06 | 2003-12-10 | Addex Pharmaceuticals Sa | Novel compounds |
AU2005250077B2 (en) | 2004-03-01 | 2011-06-09 | Idorsia Pharmaceuticals Ltd | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives |
WO2005113522A1 (fr) | 2004-05-07 | 2005-12-01 | Janssen Pharmaceutica, N.V. | Inhibiteurs carboxamides d'azole de systèmes bactériens de sécrétion de protéine de type iii |
EP1604989A1 (fr) | 2004-06-08 | 2005-12-14 | Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft | Inhibiteurs de DPP-IV |
US20060019975A1 (en) | 2004-07-23 | 2006-01-26 | Pfizer Inc | Novel piperidyl derivatives of quinazoline and isoquinoline |
GB0510142D0 (en) | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds A1 |
HUP0500920A2 (en) | 2005-10-05 | 2007-07-30 | Richter Gedeon Nyrt | Oxadiazole derivatives, process for their preparation and their use |
CA2644010A1 (fr) | 2006-03-15 | 2007-09-20 | Actelion Pharmaceuticals Ltd | Derives de tetrahydroisoquinoleine pour renforcer la fonction de la memoire |
AU2007272854B2 (en) | 2006-07-14 | 2013-08-01 | Merck Sharp & Dohme Corp. | Bridged diazepan orexin receptor antagonists |
US7994336B2 (en) | 2006-08-15 | 2011-08-09 | Actelion Pharmaceuticals Ltd. | Azetidine compounds as orexin receptor antagonists |
WO2008038251A2 (fr) * | 2006-09-29 | 2008-04-03 | Actelion Pharmaceuticals Ltd | Dérivés du 3-aza-bicyclo[3.1.0]hexane |
US8124623B2 (en) | 2006-11-10 | 2012-02-28 | Actelion Pharmaceuticals Ltd. | 5-hydroxymethyl-oxazolidin-2-one-derivatives and their uses as antibacterials |
PE20081229A1 (es) | 2006-12-01 | 2008-08-28 | Merck & Co Inc | Antagonistas de receptor de orexina de diazepam sustituido |
TW200833328A (en) | 2006-12-28 | 2008-08-16 | Actelion Pharmaceuticals Ltd | 2-aza-bicyclo[3.1.0]hexane derivatives |
WO2008087611A2 (fr) | 2007-01-19 | 2008-07-24 | Actelion Pharmaceuticals Ltd | Dérivés de pyrrolidine et de piperidine |
CL2008000836A1 (es) | 2007-03-26 | 2008-11-07 | Actelion Pharmaceuticals Ltd | Compuestos derivados de tiazolidina, antagonistas del receptor de orexina; composicion farmaceutica que los comprende; y su uso en el tratamiento de neurosis emocional, depresion grave, trastornos psicoticos, alzheimer, parkinson, dolor, entre otras. |
JP2010526869A (ja) | 2007-05-14 | 2010-08-05 | アクテリオン ファーマシューティカルズ リミテッド | 2−シクロプロピル−チアゾール誘導体 |
US7741347B2 (en) | 2007-05-17 | 2010-06-22 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
WO2008150364A1 (fr) | 2007-05-23 | 2008-12-11 | Merck & Co., Inc. | Antagonistes du récepteur de la cyclopropylpyrrolidine orexine |
GB0712888D0 (en) | 2007-07-03 | 2007-08-15 | Glaxo Group Ltd | Novel compounds |
EP2164847B1 (fr) | 2007-07-03 | 2011-09-14 | Actelion Pharmaceuticals Ltd. | Composés 3-aza-bicyclo[3.3.0]octane |
AR067396A1 (es) | 2007-07-03 | 2009-10-07 | Glaxo Group Ltd | Compuesto derivado de imidazo(1,2-a)piridin-2-ilmetil piperidina sustituida sal hidrocloruro del mismo uso del compuesto o de la sal hidrocloruro para la preparacion de un medicamento y composiciones farmaceuticas que los comprende |
US7751938B2 (en) | 2007-07-05 | 2010-07-06 | Panasonic Corporation | Robot arm control device and control method, robot, and control program |
DE602008004265D1 (de) | 2007-07-27 | 2011-02-10 | Actelion Pharmaceuticals Ltd | Trans-3-aza-bicyclo-ä3.1.0ü-hexan-derivate |
AR067665A1 (es) | 2007-07-27 | 2009-10-21 | Actelion Pharmaceuticals Ltd | Derivados de trans-3- aza-biciclo ( 3.1.0) hexano |
NZ583487A (en) | 2007-07-27 | 2011-09-30 | Actelion Pharmaceuticals Ltd | 2-aza-bicyclo[3.3.0]octane derivatives |
CA2699328A1 (fr) | 2007-09-24 | 2009-04-02 | Actelion Pharmaceuticals Ltd | Pyrrolidines et piperidines en tant qu'antagonistes du recepteur de l'orexine |
PE20091010A1 (es) | 2007-10-10 | 2009-08-08 | Actelion Pharmaceuticals Ltd | Derivados de tetrahidroquinolina |
PL2225231T3 (pl) | 2007-12-18 | 2012-01-31 | Actelion Pharmaceuticals Ltd | Pochodne aminotriazolu jako agoniści ALX |
JP2011512400A (ja) * | 2008-02-21 | 2011-04-21 | アクテリオン ファーマシューティカルズ リミテッド | 2−アザ−ビシクロ[2.2.1]ヘプタン誘導体 |
GB0806536D0 (en) | 2008-04-10 | 2008-05-14 | Glaxo Group Ltd | Novel compounds |
CN102083827A (zh) | 2008-07-07 | 2011-06-01 | 埃科特莱茵药品有限公司 | 作为食欲素受体拮抗剂的噻唑烷化合物 |
WO2010038200A1 (fr) | 2008-10-01 | 2010-04-08 | Actelion Pharmaceuticals Ltd | Composés d'oxazolidine utilisables en tant qu'antagonistes des récepteurs à orexine |
KR20110071004A (ko) | 2008-10-14 | 2011-06-27 | 액테리온 파마슈티칼 리미티드 | 페네틸아미드 유도체 및 이의 헤테로시클릭 유사체 |
WO2010048012A1 (fr) | 2008-10-21 | 2010-04-29 | Merck Sharp & Dohme Corp. | Antagonistes de récepteur d’orexine de pipéridine 2,5-disubstituée |
JP2012509911A (ja) | 2008-11-26 | 2012-04-26 | グラクソ グループ リミテッド | 新規の化合物 |
JP2012509910A (ja) | 2008-11-26 | 2012-04-26 | グラクソ グループ リミテッド | 新規の化合物 |
EP2358713A1 (fr) | 2008-11-26 | 2011-08-24 | Glaxo Group Limited | Dérivés de l imidazopyridazine agissant en tant qu antagonistes de l orexine |
CA2745433A1 (fr) | 2008-12-02 | 2010-06-10 | Glaxo Group Ltd. | Derives de n-{[(1r,4s,6r)-3-(2-pyridinylcarbonyl)-3-azabicyclo[4.1.0]hept-4-yl]methyl}-2-heteroarylamine et leurs utilisations |
JP2012510493A (ja) | 2008-12-02 | 2012-05-10 | グラクソ グループ リミテッド | N−{[(ir、4s、6r)−3−(2−ピリジニルカルボニル)−3−アザビシクロ[4.1.0]ヘプタ−4−イル]メチル}−2−ヘテロアリールアミン誘導体およびその使用 |
GB0823467D0 (en) | 2008-12-23 | 2009-01-28 | Glaxo Group Ltd | Novel Compounds |
US20120035214A1 (en) | 2009-04-03 | 2012-02-09 | Merck Canada Inc. | Renin inhibitors |
CN102459229A (zh) | 2009-04-24 | 2012-05-16 | 葛兰素集团有限公司 | 用作食欲肽拮抗剂的3-氮杂二环[4.1.0]庚烷 |
EP2440555B1 (fr) | 2009-06-09 | 2016-05-18 | Actelion Pharmaceuticals Ltd | Dérivés fluorés de l'aminotriazole |
US8680275B2 (en) | 2009-10-23 | 2014-03-25 | Janssen Pharmaceutica Nv | Fused heterocyclic compounds as orexin receptor modulators |
JP5759470B2 (ja) | 2009-10-23 | 2015-08-05 | ヤンセン ファーマシューティカ エヌ.ベー. | オレキシン受容体調節因子としての二置換オクタヒドロピロロ[3,4−c]ピロール |
JP5848251B2 (ja) | 2009-10-23 | 2016-01-27 | ヤンセン ファーマシューティカ エヌ.ベー. | オレキシン受容体調節因子としての縮合複素環式化合物 |
US8735384B2 (en) | 2010-01-19 | 2014-05-27 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
CA2807000C (fr) | 2010-08-24 | 2018-12-04 | Actelion Pharmaceuticals Ltd | Derives de proline sulfonamide comme antagonistes des recepteurs de l'orexine |
CA2812699A1 (fr) | 2010-09-24 | 2012-03-29 | Bristol-Myers Squibb Company | Inhibiteurs du virus de l'hepatite c |
US9242970B2 (en) | 2010-11-10 | 2016-01-26 | Actelion Pharmaceuticals Ltd. | Lactam derivatives useful as orexin receptor antagonists |
ES2541531T3 (es) | 2011-02-18 | 2015-07-21 | Actelion Pharmaceuticals Ltd. | Nuevos derivados de pirazol e imidazol útiles como antagonistas de orexina |
TWI565703B (zh) | 2011-11-08 | 2017-01-11 | 艾克泰聯製藥有限公司 | 2-(1,2,3-三唑-2-基)苯甲醯胺及3-(1,2,3-三唑-2-基)吡啶醯胺衍生物 |
EP2855453B1 (fr) * | 2012-06-04 | 2016-12-07 | Actelion Pharmaceuticals Ltd. | Dérivés de benzimidazole-proline |
CN104703980B (zh) | 2012-10-10 | 2017-09-22 | 埃科特莱茵药品有限公司 | 属于[邻双(杂)芳基]‑[2‑(间双(杂)芳基)吡咯烷‑1‑基]甲酮衍生物的食欲素受体拮抗剂 |
KR20150130413A (ko) | 2013-03-12 | 2015-11-23 | 액테리온 파마슈티칼 리미티드 | 오렉신 수용체 길항제로서의 아제티딘 아미드 유도체 |
PT3077389T (pt) * | 2013-12-03 | 2017-12-15 | Idorsia Pharmaceuticals Ltd | Forma cristalina de (s)-(2-(6-cloro-7-metil-1hbenzo[d]imidazol-2-il)-2-metilpirrolidin-1-il)(5-metoxi-2-(2h-1,2,3-triazol-2-il)fenil)metanona e a sua utilização como como antagonistas do receptor de orexina |
UA119151C2 (uk) | 2013-12-03 | 2019-05-10 | Ідорсія Фармасьютікалз Лтд | КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА |
LT3077391T (lt) | 2013-12-04 | 2018-10-25 | Idorsia Pharmaceuticals Ltd | Benzimidazolo prolino darinių panaudojimas |
-
2013
- 2013-06-03 EP EP13744805.6A patent/EP2855453B1/fr active Active
- 2013-06-03 JP JP2015515624A patent/JP5814491B2/ja active Active
- 2013-06-03 CA CA2873341A patent/CA2873341C/fr active Active
- 2013-06-03 NZ NZ703448A patent/NZ703448A/en unknown
- 2013-06-03 AR ARP130101954 patent/AR091257A1/es active IP Right Grant
- 2013-06-03 KR KR1020157000154A patent/KR101689093B1/ko active IP Right Grant
- 2013-06-03 TW TW104132248A patent/TWI570120B/zh active
- 2013-06-03 HU HUE13744805A patent/HUE031753T2/en unknown
- 2013-06-03 SI SI201330557A patent/SI2855453T1/sl unknown
- 2013-06-03 SG SG11201408004SA patent/SG11201408004SA/en unknown
- 2013-06-03 CN CN201380029097.2A patent/CN104334544B/zh active Active
- 2013-06-03 TW TW102119632A patent/TWI510481B/zh active
- 2013-06-03 PL PL13744805T patent/PL2855453T3/pl unknown
- 2013-06-03 LT LTEP13744805.6T patent/LT2855453T/lt unknown
- 2013-06-03 EA EA201401351A patent/EA028046B1/ru not_active IP Right Cessation
- 2013-06-03 DK DK13744805.6T patent/DK2855453T3/en active
- 2013-06-03 MX MX2014014885A patent/MX354102B/es active IP Right Grant
- 2013-06-03 MY MYPI2014703599A patent/MY169986A/en unknown
- 2013-06-03 BR BR112014030173-5A patent/BR112014030173B1/pt active IP Right Grant
- 2013-06-03 SG SG10201702540UA patent/SG10201702540UA/en unknown
- 2013-06-03 WO PCT/IB2013/054567 patent/WO2013182972A1/fr active Application Filing
- 2013-06-03 KR KR1020187029604A patent/KR101995683B1/ko active IP Right Grant
- 2013-06-03 ES ES13744805T patent/ES2617863T3/es active Active
- 2013-06-03 US US14/405,649 patent/US9732075B2/en active Active
- 2013-06-03 AU AU2013273222A patent/AU2013273222B2/en active Active
- 2013-06-03 KR KR1020167019098A patent/KR101946128B1/ko active IP Right Grant
- 2013-06-03 EA EA201600366A patent/EA029899B1/ru not_active IP Right Cessation
- 2013-06-03 PT PT137448056T patent/PT2855453T/pt unknown
-
2014
- 2014-11-14 PH PH12014502540A patent/PH12014502540A1/en unknown
- 2014-12-02 CL CL2014003294A patent/CL2014003294A1/es unknown
- 2014-12-02 IL IL236024A patent/IL236024A/en active IP Right Grant
- 2014-12-19 ZA ZA2014/09422A patent/ZA201409422B/en unknown
-
2015
- 2015-09-16 HK HK15109034.2A patent/HK1208449A1/xx unknown
-
2017
- 2017-02-28 CY CY20171100269T patent/CY1118735T1/el unknown
- 2017-03-02 HR HRP20170351TT patent/HRP20170351T1/hr unknown
- 2017-07-07 US US15/644,547 patent/US10329287B2/en active Active
-
2019
- 2019-05-07 US US16/405,797 patent/US11040966B2/en active Active
-
2022
- 2022-08-31 LT LTPA2022518C patent/LTPA2022518I1/lt unknown
- 2022-09-01 HU HUS2200040C patent/HUS2200040I1/hu unknown
- 2022-09-13 FR FR22C1047C patent/FR22C1047I2/fr active Active
- 2022-09-28 NL NL301197C patent/NL301197I2/nl unknown
- 2022-10-27 NO NO2022044C patent/NO2022044I1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR22C1047I2 (fr) | Derives de benzimidazole-proline | |
SMT201700065B (it) | Derivato piridonico | |
DK2859055T3 (da) | Polymercoatings | |
DK2825087T3 (da) | Otoscanner | |
DK2839013T3 (da) | Ikke-disruptiv-gen-targetering | |
CO6990736A2 (es) | Pirrolidina-2-carboxamidas sustituídas | |
DK2873977T3 (da) | Dobbeltdækker-rørdispenser | |
DE112012006109A5 (de) | Okklusionsschienenanordnung | |
DK2854722T3 (da) | Stomipose | |
AR092198A1 (es) | Derivados de pirazolopirimidinas | |
CO7020919A2 (es) | Derivados de tetrahidro-quinazolinona | |
DK2825157T3 (da) | Aminosyrelipider | |
CO6960557A2 (es) | Derivados de 2-yodo-imidazol | |
DK2831122T3 (da) | Anthocyanidin-kompleks | |
DE112012006214T8 (de) | Wulstringwickler | |
CO7020920A2 (es) | Derivado de fenilazol sustituido | |
DE112012005566T8 (de) | Seltenerdnanoverbundmagnet | |
FI20126082A (fi) | Kaasunvaihtoventtiilijärjestely | |
DK2885638T3 (da) | Molekylenet | |
DK2858657T3 (da) | Feijoafrugtekstrakt | |
FI20126157A (fi) | Laajentumistila | |
FI20125844A (fi) | Talotekniikkamoduuli | |
ES1077590Y (es) | Columbario | |
FR2999576B1 (fr) | Derives de testosterone | |
DE102013212400A8 (de) | Abdeckplattenstützbaugruppe |